ロチゴチンの鼻腔内用処方 - SCHWARZ PHARMA AKTIENGESELLSCHAFT

Title:

ロチゴチンの鼻腔内用処方

Document Type and Number:

Japanese Patent JP2006526004

Kind Code:

A

Abstract:

This invention pertains to a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and alpha -cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5 - 1.5 mm<2>/s

More Like This:

JP2018197252	METHODS OF TREATING MUSCULAR DYSTROPHY
JP4351842	Sugar Substitution 2-Azetidinone Useful as a Hypocholesterolemia Agent
JP2021529780	Methods of Treatment or Selection of Treatment for Subjects Resistant to TNF Inhibitors Using NLRP3 Antagonists

Inventors:

Robert Kramer

Application Number:

JP2006508291A

Publication Date:

November 16, 2006

Filing Date:

December 22, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SCHWARZ PHARMA AKTIENGESELLSCHAFT

International Classes:

A61K31/381; A61K9/08; A61K47/04; A61K47/10; A61K47/12; A61K47/14; A61K47/40; A61P25/16; A61P43/00

Attorney, Agent or Firm:

Mitsuo Tanaka
Tadayuki Motoyama
Kenji Tomita

Previous Patent: ベンゾチアゾール誘導体、およびアデノシンＡ２Ａ受容体に関連した疾患�...

Next Patent: チロシナーゼ阻害剤としてのジフェニルメタン誘導体の使用